Spherix Announces New Interim Chief Executive Officer
February 28, 2013 12:10 ET
|
Spherix Incorporated
TYSONS CORNER, Va., Feb. 28, 2013 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nasdaq:SPEX) – today announced the naming of an interim Chief Executive Officer. Harvey Kesner, currently a director,...
Spherix Announces Restructuring
December 03, 2012 08:36 ET
|
Spherix Incorporated
BETHESDA, Md., Dec. 3, 2012 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nasdaq:SPEX) – today announced that, as an initial step in its restructuring program, it has sold all of the stock of...
Spherix Announces Third Quarter 2012 Financial Results
November 15, 2012 14:45 ET
|
Spherix Incorporated
BETHESDA, Md., Nov. 15, 2012 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nasdaq:SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider...
Spherix and Fullife Healthcare Sign Supply and License Agreement for D-Tagatose in Nutraceutical Products in India
November 15, 2012 09:56 ET
|
Spherix Incorporated
BETHESDA, Md. and MUMBAI, India, Nov. 15, 2012 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nasdaq:SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and...
Spherix Announces Closing of Private Placement of $2.6 Million in Common Stock and Warrants
November 12, 2012 12:29 ET
|
Spherix Incorporated
BETHESDA, Md., Nov. 12, 2012 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nasdaq:SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider...
Spherix to Raise $2.6 Million in Private Placement
November 08, 2012 14:51 ET
|
Spherix Incorporated
BETHESDA, M.D., Nov. 8, 2012 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nasdaq:SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider...
Spherix Announces Reverse Stock Split Effective September 21, 2012
September 21, 2012 10:07 ET
|
Spherix Incorporated
BETHESDA, Md., Sept. 21, 2012 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nasdaq: SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and...
Spherix to Effect Reverse Stock Split
September 06, 2012 12:15 ET
|
Spherix Incorporated
BETHESDA, Md., Sept. 6, 2012 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nasdaq:SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider...
Spherix Incorporated to Present at the Rodman & Renshaw 14th Annual Healthcare Conference
September 04, 2012 09:20 ET
|
Spherix Incorporated
BETHESDA, Md., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nasdaq:SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider...
Photo Release -- Preclinical Study With SPX106T Reduces Growth Rate of Abdominal Aortic Aneurysms
August 13, 2012 14:16 ET
|
Spherix Incorporated
BETHESDA, Md., Aug. 13, 2012 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nadsaq:SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider...